Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

2(40.0%)

N/A

2(40.0%)

Phase 4

1(20.0%)

5Total

Phase 3(2)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04363294Not ApplicableWithdrawn

Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot

Role: collaborator

NCT02145481Not ApplicableCompleted

Decisional Quality for Patients With Coronary Artery Disease

Role: collaborator

NCT02767232Phase 3Withdrawn

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Role: collaborator

NCT00790335Phase 3Completed

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Role: collaborator

NCT00976053Phase 4Completed

Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging

Role: collaborator

NCT01373944Completed

Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI

Role: collaborator

All 6 trials loaded